Table 5 MIC of Enterobacter sink isolates, DH5 alpha transconjugant (TG) and parental recipient strain used in mating experiments
Antimicrobic | E. hormachei 18-216 | E. hormachei 18-242-2 | DH5 alpha_TG | DH5 alpha |
|---|---|---|---|---|
Amikacin | ≤ 4 | ≤ 4 | ≤ 4 | ≤ 4 |
Amoxicillin/Clavulanic Acid |  > 8 |  > 8 | = 8 | = 4 |
Ampicillin |  > 8 |  > 8 |  > 8 | = 2 |
Aztreonam |  > 16 |  > 16 |  > 16 | n/d |
Cefalexin |  > 16 |  > 16 | = 16 | = 4 |
Cefazolin |  > 32 |  > 32 | = 32 | = 2 |
Cefepime | ≤ 2 | ≤ 2 | ≤ 2 | n/d |
Cefotaxime | = 8 | = 8 | = 2 | n/d |
Cefovecin |  > 8 |  > 8 | = 8 | = 0.5 |
Cefpodoxime |  > 8 |  > 8 | = 8 | ≤ 1 |
Ceftazidime |  > 16 |  > 16 | = 16 | ≤ 4 |
Chloramphenicol |  > 32 |  > 32 |  > 32 | ≤ 2 |
Ciprofloxacin | ≤ 0.25 | ≤ 0.25 | ≤ 0.25 | n/d |
Colistin | ≤ 0.25 | ≤ 0.25 | ≤ 0.25 | n/d |
Doripenem | ≤ 0.12 | ≤ 0.12 | ≤ 0.12 | n/d |
Doxycycline |  > 16 |  > 16 | = 16 | = 0.5 |
Enrofloxacin | = 1 | = 1 | ≤ 0.12 | ≤ 0.12 |
Ertapenem | ≤ 0.25 | ≤ 0.25 | ≤ 0.25 | n/d |
Gentamicin |  > 8 |  > 8 |  > 8 | ≤ 0.25 |
Imipenem | ≤ 1 | ≤ 1 | ≤ 1 | ≤ 1 |
Levofloxacin | ≤ 1 | ≤ 1 | ≤ 1 | n/d |
Marbofloxacin | = 0.5 | = 0.5 | ≤ 0.12 | ≤ 0.12 |
Meropenem | ≤ 1 | ≤ 1 | ≤ 1 | n/d |
Minocycline | = 16 | = 16 | = 8 | n/d |
Orbifloxacin | = 4 | = 4 | ≤ 1 | ≤ 1 |
Piperacillin/tazobactam constant 4 | ≤ 8 | ≤ 8 | ≤ 8 | ≤ 8 |
Polymixin | ≤ 0.25 | ≤ 0.25 | ≤ 0.25 | n/d |
Pradofloxacin | = 0.5 | = 0.5 | ≤ 0.25 | ≤ 0.25 |
Tetracycline |  > 16 |  > 16 |  > 16 | ≤ 4 |
Ticarcillin/clavulanic acid constant 2 | = 32 | = 32 | = 32 | n/d |
Tigecycline | = 0.5 | = 0.5 | = 0.5 | n/d |
Tobramycin | = 8 |  > 8 | = 2 | n/d |
Trimethoprim/sulfamethoxazole |  > 4 |  > 4 |  > 4 | ≤ 0.5 |